Target Validation Information
TTD ID T13201
Target Name Carbonic anhydrase I (CA-I)
Type of Target
Successful
Drug Potency against Target (2-bromophenyl)difluoromethanesulfonamide Drug Info Ki = 5200 nM [18]
(4-bromophenyl)difluoromethanesulfonamide Drug Info Ki = 273 nM [18]
1,4-Dihydro-1-methyl-4-oxo-3-pyridinesulfonamide Drug Info Ki = 3440 nM [43]
1-acetamido-5-sulfonamidoindane Drug Info Ki = 8.5 nM [8]
1-Benzyl-1,4-dihydro-4-oxo-3-pyridinesulfonamide Drug Info Ki = 4120 nM [43]
1-cyclohexylamido-5-sulfonamidoindane Drug Info Ki = 880 nM [19]
1-pentafluorophenylamido-5-sulfonamidoindane Drug Info Ki = 770 nM [19]
1-valproylamido-5-sulfonamidoindane Drug Info Ki = 810 nM [19]
2,2,2-Trifluoro-N-(4-sulfamoyl-phenyl)-acetamide Drug Info Ki = 14600 nM [17]
2,3-dihydro-1H-indene-5-sulfonamide Drug Info Ki = 215 nM [8]
2,4-dichloro-5-sulfamoylbenzoic acid Drug Info IC50 = 7700 nM [39]
2,4-Disulfamyltrifluoromethylaniline Drug Info Ki = 5800 nM [51]
2-(4-chlorobenzyloxyamino)-N-hydroxyacetamide Drug Info Ki = 10000 nM [22]
2-(4-chlorobenzyloxyamino)-N-hydroxyhexanamide Drug Info Ki = 10200 nM [22]
2-(4-chlorobenzyloxyamino)-N-hydroxypropanamide Drug Info Ki = 9800 nM [22]
2-(biphenyl-4-yl)vinylboronic acid Drug Info Ki = 10700 nM [34]
2-acetamido-5-sulfonamidoindane Drug Info Ki = 2510 nM [19]
2-Acetylamino-indan-5-sulfonic acid hydrate Drug Info Ki = 89 nM [8]
2-Amino-indan-5-sulfonic acid Drug Info Ki = 43 nM [8]
2-butylamido-5-sulfonamidoindane Drug Info Ki = 875 nM [19]
2-cyclohexylamido-5-sulfonamidoindane Drug Info Ki = 3560 nM [19]
2-ethylamido-5-sulfonamidoindane Drug Info Ki = 3440 nM [19]
2-Hydroxycinnamic acid Drug Info Ki = 3100 nM [47]
2-Mercapto-N-(4-sulfamoyl-phenyl)-benzamide Drug Info Ki = 276 nM [24]
2-Morpholin-4-yl-N-(4-sulfamoyl-phenyl)-acetamide Drug Info Ki = 9.6 nM [9]
2-nonylamido-5-sulfonamidoindane Drug Info Ki = 5330 nM [19]
2-oxo-2H-chromene-3-carboxylic acid Drug Info Ki = 9300 nM [38]
2-oxo-2H-thiochromene-3-carboxylic acid Drug Info Ki = 12400 nM [38]
2-pentafluorophenylamido-5-sulfonamidoindane Drug Info Ki = 600 nM [19]
2-propylamido-5-sulfonamidoindane Drug Info Ki = 825 nM [19]
2-valproylamido-5-sulfonamidoindane Drug Info Ki = 4130 nM [19]
3-(3-Phenyl-ureido)-benzenesulfonamide Drug Info Ki = 1500 nM [17]
3-(4-sulfamoylphenyl)propanoic acid Drug Info Ki = 6690 nM [51]
3-bromophenyl-difluoromethanesulfonamide Drug Info Ki = 1095 nM [18]
3-Chloro-4-hydrazino-benzenesulfonamide Drug Info Ki = 2800 nM [12]
3-Fluoro-4-hydrazino-benzenesulfonamide Drug Info Ki = 3300 nM [12]
3-mercapto-N-(4-sulfamoyl-phenyl)-propionamide Drug Info Ki = 74 nM [20]
3-phenyl-5-sulfamoyl-1H-indole-2-carboxamide Drug Info Ki = 48 nM [35]
3-phenylprop-1-enylboronic acid Drug Info Ki = 8600 nM [34]
4,4'-thiodipyridine-3-sulfonamide Drug Info Ki = 11170 nM [41]
4,6-Dinitro salicylic acid Drug Info Ki = 14850 nM [28]
4-(2-AMINOETHYL)BENZENESULFONAMIDE Drug Info Ki = 2100 nM [16]
4-(2-aminopyrimidin-4-ylamino)benzenesulfonamide Drug Info Ki = 109 nM [51]
4-(2-Methyl-8-quinolinoxy)-3-pyridinesulfonamide Drug Info Ki = 10320 nM [41]
4-(2-Phenylacetamido)-3-bromobenzenesulfonamide Drug Info Ki = 263 nM [36]
4-(2-Phenylacetamido)-3-chlorobenzenesulfonamide Drug Info Ki = 61 nM [36]
4-(2-Phenylacetamido)-3-fluorobenzenesulfonamide Drug Info Ki = 67 nM [36]
4-(2-Phenylacetamido)benzenesulfonamide Drug Info Ki = 108 nM [36]
4-(2-Phenylacetamidoethyl)benzenesulfonamide Drug Info Ki = 60 nM [36]
4-(2-Phenylacetamidomethyl)benzenesulfonamide Drug Info Ki = 75 nM [36]
4-(2-Propynylthio)pyridine-3-sulfonamide Drug Info Ki = 8320 nM [41]
4-(2-Pyridin-2-ylacetamido)benzenesulfonamide Drug Info Ki = 75 nM [36]
4-(2-Pyridin-4-ylacetamido)benzenesulfonamide Drug Info Ki = 71 nM [36]
4-(4-Cyanophenoxy)-3-pyridinesulfonamide Drug Info Ki = 6640 nM [41]
4-(4-Fluorophenoxy)-3-pyridinesulfonamide Drug Info Ki = 9160 nM [41]
4-(5-Methyl-2-pirazolino)-3-pyridinesulfonamide Drug Info Ki = 10300 nM [41]
4-(Allylamino)-3-pyridinesulfonamide Drug Info Ki = 8860 nM [41]
4-(Carbamolymethylthio)pyridine-3-sulfonamide Drug Info Ki = 9510 nM [41]
4-(Cyanomethylthio)pyridine-3-sulfonamide Drug Info Ki = 11710 nM [41]
4-(hydroxymethyl)benzenesulfonamide Drug Info Ki = 55 nM [51]
4-(Methylhydrazino)-3-pyridinesulfonamide Drug Info Ki = 5620 nM [41]
4-(N-Oxide-2-pyridylthio)pyridine-3-sulfonamide Drug Info Ki = 7620 nM [41]
4-(Quinolinoxy)-3-pyridinesulfonamide Drug Info Ki = 10320 nM [41]
4-Amino-3-bromo-benzenesulfonamide Drug Info Ki = 6500 nM [51]
4-Amino-3-chloro-benzenesulfonamide Drug Info Ki = 9800 nM [51]
4-Amino-3-fluoro-benzenesulfonamide Drug Info Ki = 8300 nM [46]
4-Amino-3-iodo-benzenesulfonamide Drug Info Ki = 6000 nM [51]
4-amino-6-chlorobenzene-1,3-disulfonamide Drug Info Ki = 8400 nM [46]
4-amino-N-(4-sulfamoylbenzyl)benzenesulfonamide Drug Info Ki = 164 nM [51]
4-azidobenzenesulfonamide Drug Info Ki = 3900 nM [27]
4-Benzenesulfonylamino-benzenesulfonamide Drug Info Ki = 103 nM [17]
4-Benzythiopyridine-3-sulfonamide Drug Info Ki = 9090 nM [41]
4-bromophenylboronic acid Drug Info Ki = 11700 nM [34]
4-butylphenylboronic acid Drug Info Ki = 7900 nM [34]
4-Chloro-N-(5-sulfamoyl-indan-2-yl)-benzamide Drug Info Ki = 36 nM [8]
4-Ethoxy-3-pyridinesulfonamide Drug Info Ki = 6100 nM [41]
4-ethynyl benzene sulfonamide Drug Info Ki = 1080 nM [23]
4-fluoro-N-(4-sulfamoylbenzyl)benzenesulfonamide Drug Info Ki = 870 nM [30]
4-Hydrazino-3-pyridinesulfonamide Drug Info Ki = 7910 nM [41]
4-Hydrazino-benzenesulfonamide Drug Info Ki = 3900 nM [12]
4-isothiocyanatobenzenesulfonamide Drug Info Ki = 5000 nM [4]
4-Methanesulfonylamino-benzenesulfonamide Drug Info Ki = 125 nM [17]
4-Methoxy-3-pyridinesulfonamide Drug Info Ki = 7340 nM [41]
4-methoxyphenylboronic acid Drug Info Ki = 10900 nM [34]
4-methylphenyl-difluoromethanesulfonamide Drug Info Ki = 952 nM [18]
4-methylstyrylboronic acid Drug Info Ki = 12100 nM [34]
4-Methylthiopyridine-3-sulfonamide Drug Info Ki = 9030 nM [41]
4-nitrophenyl phosphate Drug Info IC50 = 330 nM [49]
4-nitrophenyl-difluoromethanesulfonamide Drug Info Ki = 1130 nM [18]
4-phenoxyphenylboronic acid Drug Info Ki = 6000 nM [34]
4-[2-(2-Thienyl)acetamidoethyl]benzenesulfonamide Drug Info Ki = 68 nM [36]
4-[2-(2-Thienyl)acetamido]benzenesulfonamide Drug Info Ki = 61 nM [36]
4-[2-(3-Phenyl-ureido)-ethyl]-benzenesulfonamide Drug Info Ki = 430 nM [17]
5-Amino-[1,3,4]thiadiazole-2-thiol Drug Info Ki = 7100 nM [14]
5-Chlorosalicylic Acid Drug Info Ki = 4160 nM [28]
5-hydroxy-1-tosyl-1H-pyrrol-2(5H)-one Drug Info Ki = 510 nM [44]
5-oxo-1-tosyl-2,5-dihydro-1Hpyrrol-2-yl acetate Drug Info Ki = 730 nM [44]
6-(aminomethyl)-2H-chromen-2-one Drug Info Ki = 99 nM [38]
6-Amino-benzothiazole-2-sulfonic acid amide Drug Info Ki = 70 nM [1]
6-Hydroxy-benzothiazole-2-sulfonic acid amide Drug Info Ki = 95 nM [31]
6-methoxy-2-oxo-2H-chromene-3-carboxylic acid Drug Info Ki = 59 nM [38]
6-methyl-2-oxo-2H-chromene-3-carboxylic acid Drug Info Ki = 6800 nM [38]
7-methoxy-2-oxo-2H-chromene-4-carboxylic acid Drug Info Ki = 3720 nM [38]
8-methoxy-2-oxo-2H-chromene-3-carboxylic acid Drug Info Ki = 66 nM [38]
Aminobenzolamide derivative Drug Info Ki = 62 nM [7]
Azide Drug Info Ki = 1200 nM [6]
BENZENESULFONAMIDE Drug Info Ki = 3300 nM [33]
BENZOLAMIDE Drug Info Ki = 15 nM [51]
Benzothiazole-2-sulfonic acid amide Drug Info Ki = 95 nM [11]
Beta-naphthylboronic acid Drug Info Ki = 6500 nM [34]
Biphenyl-4-ylboronic acid Drug Info Ki = 3700 nM [34]
Carbamoyl phosphate disodium Drug Info Ki = 9400 nM [5]
Carzenide Drug Info Ki = 3400 nM [33]
CATECHIN Drug Info Ki = 2420 nM [47]
CHLORIDE Drug Info Ki = 6 nM [3]
CL-5343 Drug Info Ki = 5900 nM [48]
COUMARIN Drug Info Ki = 3100 nM [50]
Coumate Drug Info Ki = 3450 nM [26]
Curcumin Drug Info Ki = 2410 nM [47]
CYANATE Drug Info Ki = 700 nM [6]
Cynooxide anion Drug Info Ki = 700 nM [2]
Decane-1,10-diyl disulfamate Drug Info Ki = 890 nM [37]
Decyl sulfamate Drug Info Ki = 530 nM [37]
ELLAGIC ACID Drug Info Ki = 2320 nM [40]
FERULIC ACID Drug Info Ki = 2890 nM [40]
GALLICACID Drug Info Ki = 3200 nM [40]
HERNIARIN Drug Info Ki = 5900 nM [38]
Hexane-1,6-diamine Drug Info Ki = 12600 nM [45]
HYDROSULFIDE Drug Info Ki = 600 nM [6]
INDISULAM Drug Info Ki = 31 nM [43]
IODIDE Drug Info Ki = 0.3 nM [3]
N-(4-cyanophenyl)sulfamide Drug Info Ki = 20 nM [15]
N-(4-Sulfamoyl-phenyl)-benzamide Drug Info Ki = 3300 nM [17]
N-(4-Sulfamoyl-phenyl)-butyramide Drug Info Ki = 19300 nM [17]
N-(4-Sulfamoyl-phenyl)-propionamide Drug Info Ki = 19700 nM [17]
N-(4-sulfamoylphenylethyl)-4-sulfamoylbenzamide Drug Info Ki = 40 nM
N-(5-ethyl-1,3,4-thiadiazol-2-yl)sulfamide Drug Info Ki = 7010 nM [29]
N-(5-Mercapto-[1,3,4]thiadiazol-2-yl)-acetamide Drug Info Ki = 4500 nM [14]
N-(5-phenyl-1,3,4-thiadiazol-2-yl)sulfamide Drug Info Ki = 1660 nM [29]
N-(5-tert-butyl-1,3,4-thiadiazol-2-yl)sulfamide Drug Info Ki = 5540 nM [29]
N-(pentafluorophenyl)sulfamide Drug Info Ki = 34 nM [15]
N-1,3,4-thiadiazol-2-ylsulfamide Drug Info Ki = 7420 nM [29]
N-hydroxysulfamide Drug Info Ki = 4050 nM [42]
N-propynyl amidebenzenesulphonide Drug Info Ki = 6100 nM [21]
N-[4-(trifluoromethyl)phenyl]sulfamide Drug Info Ki = 8000 nM [15]
N-[5-(ethylthio)-1,3,4-thiadiazol-2-yl]sulfamide Drug Info Ki = 1890 nM [29]
N-[5-(methylthio)-1,3,4-thiadiazol-2-yl]sulfamide Drug Info Ki = 2400 nM [29]
NITRATE Drug Info Ki = 7 nM [3]
NSC-654077 Drug Info Ki = 4350 nM [24]
Octane-1,8-diyl disulfamate Drug Info Ki = 378 nM [37]
Octyl sulfamate Drug Info Ki = 3.5 nM [37]
P-Coumaric Acid Drug Info Ki = 1070 nM [40]
PARABEN Drug Info Ki = 920 nM [40]
PARAOXON Drug Info IC50 = 338 nM [49]
Pentane-1,5-diamine Drug Info Ki = 13300 nM [45]
Pentanoic acid (4-sulfamoyl-phenyl)-amide Drug Info Ki = 17650 nM [17]
Phenethylboronic acid Drug Info Ki = 11400 nM [34]
PHENOL Drug Info Ki = 10200 nM [47]
Phenoxyarsonous acid Drug Info Ki = 31.7 nM [3]
Phenyl Boronic acid Drug Info Ki = 58.6 nM [3]
PHENYLDIFLUOROMETHANESULFONAMIDE Drug Info Ki = 357 nM [18]
PHENYLMETHANESULFONAMIDE Drug Info Ki = 1250 nM [18]
PHENYLSULFAMATE Drug Info Ki = 2.1 nM [18]
Prop-2-ynyl 4-sulfamoylbenzoate Drug Info Ki = 4000 nM [21]
SACCHARIN Drug Info Ki = 18540 nM [46]
Salicyclic acid Drug Info Ki = 9900 nM [25]
Sodium trithiocarbonate Drug Info Ki = 8700 nM [32]
Styrylboronic acid Drug Info Ki = 12500 nM [34]
Sulfamic acid 12-sulfamoyloxy-dodecyl ester Drug Info Ki = 1350 nM [10]
Sulfamic acid 16-sulfamoyloxy-hexadecyl ester Drug Info Ki = 16450 nM [10]
Sulfamic acid 3-sulfamoyloxy-phenyl ester Drug Info Ki = 79 nM [10]
Sulfamic acid 4-sulfamoyloxy-butyl ester Drug Info Ki = 31 nM [10]
Sulfamic acid 6-sulfamoyloxy-hexyl ester Drug Info Ki = 136 nM [10]
Sulfamic acid 7-sulfamoyloxy-heptyl ester Drug Info Ki = 145 nM [10]
SULFAMIDE Drug Info Ki = 0.31 nM [3]
SULFATE Drug Info Ki = 63 nM [3]
Syringic Acid Drug Info Ki = 4150 nM [40]
[Au(CN)2]- Drug Info Ki = 7700 nM [13]
[Cu(CN)2]- Drug Info Ki = 6900 nM [13]
References
REF 1 Carbonic anhydrase inhibitors. Synthesis of water-soluble, topically effective, intraocular pressure-lowering aromatic/heterocyclic sulfonamides co... J Med Chem. 1999 Jul 15;42(14):2641-50.
REF 2 Carbonic anhydrase inhibitors. Inhibition of the beta-class enzyme from the methanoarchaeon Methanobacterium thermoautotrophicum (Cab) with anions. Bioorg Med Chem Lett. 2004 Sep 6;14(17):4563-7.
REF 3 Carbonic anhydrase inhibitors. Inhibition of the newly isolated murine isozyme XIII with anions. Bioorg Med Chem Lett. 2004 Nov 1;14(21):5435-9.
REF 4 Carbonic anhydrase inhibitors: the first on-resin screening of a 4-sulfamoylphenylthiourea library. J Med Chem. 2004 Oct 7;47(21):5224-9.
REF 5 Carbonic anhydrase inhibitors. Interaction of isozymes I, II, IV, V, and IX with phosphates, carbamoyl phosphate, and the phosphonate antiviral dru... Bioorg Med Chem Lett. 2004 Dec 6;14(23):5763-7.
REF 6 Carbonic anhydrase inhibitors: inhibition of the membrane-bound human isozyme IV with anions. Bioorg Med Chem Lett. 2004 Dec 6;14(23):5769-73.
REF 7 Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides d... Bioorg Med Chem Lett. 2004 Dec 6;14(23):5775-80.
REF 8 Carbonic anhydrase inhibitors. Design of anticonvulsant sulfonamides incorporating indane moieties. Bioorg Med Chem Lett. 2004 Dec 6;14(23):5781-6.
REF 9 Carbonic anhydrase inhibitors. Novel sulfanilamide/acetazolamide derivatives obtained by the tail approach and their interaction with the cytosolic... Bioorg Med Chem Lett. 2005 Jan 17;15(2):367-72.
REF 10 Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with bis-sulfamates. Bioorg Med Chem Lett. 2005 Feb 1;15(3):579-84.
REF 11 Carbonic anhydrase inhibitors. Inhibition of the human cytosolic isozyme VII with aromatic and heterocyclic sulfonamides. Bioorg Med Chem Lett. 2005 Feb 15;15(4):971-6.
REF 12 Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/membrane-associated carbonic anhydrase isozymes I, II, and IX with sulfonamide... J Med Chem. 2005 Mar 24;48(6):2121-5.
REF 13 Carbonic anhydrase inhibitors. Inhibition of isozymes I, II, IV, V and IX with complex fluorides, chlorides and cyanides. Bioorg Med Chem Lett. 2005 Apr 1;15(7):1909-13.
REF 14 Carbonic anhydrase inhibitors. Inhibition of the cytosolic and tumor-associated carbonic anhydrase isozymes I, II, and IX with a series of 1,3,4-th... Bioorg Med Chem Lett. 2005 May 2;15(9):2347-52.
REF 15 Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, IX, and XII with N-hydroxy... Bioorg Med Chem Lett. 2005 May 2;15(9):2353-8.
REF 16 Carbonic anhydrase inhibitors. Design of fluorescent sulfonamides as probes of tumor-associated carbonic anhydrase IX that inhibit isozyme IX-media... J Med Chem. 2005 Jul 28;48(15):4834-41.
REF 17 Carbonic anhydrase inhibitors: inhibition of the tumor-associated isozymes IX and XII with a library of aromatic and heteroaromatic sulfonamides. Bioorg Med Chem Lett. 2005 Nov 1;15(21):4862-6.
REF 18 Carbonic anhydrase inhibitors: inhibition of the human isozymes I, II, VA, and IX with a library of substituted difluoromethanesulfonamides. Bioorg Med Chem Lett. 2005 Dec 1;15(23):5192-6.
REF 19 Indanesulfonamides as carbonic anhydrase inhibitors. Toward structure-based design of selective inhibitors of the tumor-associated isozyme CA IX. J Med Chem. 2006 May 4;49(9):2743-9.
REF 20 Carbonic anhydrase inhibitors: Hypoxia-activatable sulfonamides incorporating disulfide bonds that target the tumor-associated isoform IX. J Med Chem. 2006 Sep 7;49(18):5544-51.
REF 21 A novel class of carbonic anhydrase inhibitors: glycoconjugate benzene sulfonamides prepared by "click-tailing". J Med Chem. 2006 Nov 2;49(22):6539-48.
REF 22 Carbonic anhydrase and matrix metalloproteinase inhibitors. Inhibition of human tumor-associated isozymes IX and cytosolic isozyme I and II with su... Bioorg Med Chem. 2007 Mar 15;15(6):2298-311.
REF 23 Inhibition of carbonic anhydrases with glycosyltriazole benzene sulfonamides. J Med Chem. 2008 Mar 27;51(6):1945-53.
REF 24 Recent developments of carbonic anhydrase inhibitors as potential anticancer drugs. J Med Chem. 2008 Jun 12;51(11):3051-6.
REF 25 Carbonic anhydrase inhibitors: inhibition of mammalian isoforms I-XIV with a series of substituted phenols including paracetamol and salicylic acid. Bioorg Med Chem. 2008 Aug 1;16(15):7424-8.
REF 26 Carbonic anhydrase inhibitors. Interaction of the antitumor sulfamate EMD 486019 with twelve mammalian carbonic anhydrase isoforms: Kinetic and X-r... Bioorg Med Chem Lett. 2008 Aug 1;18(15):4282-6.
REF 27 Inhibition of human mitochondrial carbonic anhydrases VA and VB with para-(4-phenyltriazole-1-yl)-benzenesulfonamide derivatives. Bioorg Med Chem Lett. 2008 Aug 15;18(16):4624-7.
REF 28 In vitro inhibition of salicylic acid derivatives on human cytosolic carbonic anhydrase isozymes I and II. Bioorg Med Chem. 2008 Oct 15;16(20):9101-5.
REF 29 Carbonic anhydrase inhibitors: 2-substituted-1,3,4-thiadiazole-5-sulfamides act as powerful and selective inhibitors of the mitochondrial isozymes ... Bioorg Med Chem Lett. 2008 Dec 15;18(24):6332-5.
REF 30 Ligand-based and structure-based virtual screening to identify carbonic anhydrase IX inhibitors. Bioorg Med Chem. 2009 Jan 15;17(2):553-7.
REF 31 Cloning, expression, post-translational modifications and inhibition studies on the latest mammalian carbonic anhydrase isoform, CA XV. J Med Chem. 2009 Feb 12;52(3):646-54.
REF 32 Carbonic anhydrase inhibitors. Inhibition of cytosolic isoforms I, II, III, VII and XIII with less investigated inorganic anions. Bioorg Med Chem Lett. 2009 Apr 1;19(7):1855-7.
REF 33 Ligand-directed tosyl chemistry for protein labeling in vivo. Nat Chem Biol. 2009 May;5(5):341-3.
REF 34 Carbonic anhydrase inhibitors. Inhibition of the fungal beta-carbonic anhydrases from Candida albicans and Cryptococcus neoformans with boronic acids. Bioorg Med Chem Lett. 2009 May 15;19(10):2642-5.
REF 35 Discovery of low nanomolar and subnanomolar inhibitors of the mycobacterial beta-carbonic anhydrases Rv1284 and Rv3273. J Med Chem. 2009 Jul 9;52(13):4063-7.
REF 36 Carbonic anhydrase inhibitors. Aromatic/heterocyclic sulfonamides incorporating phenacetyl, pyridylacetyl and thienylacetyl tails act as potent inh... Bioorg Med Chem. 2009 Jul 15;17(14):4894-9.
REF 37 Carbonic anhydrase inhibitors. Comparison of aliphatic sulfamate/bis-sulfamate adducts with isozymes II and IX as a platform for designing tight-bi... J Med Chem. 2009 Oct 8;52(19):5990-8.
REF 38 Deciphering the mechanism of carbonic anhydrase inhibition with coumarins and thiocoumarins. J Med Chem. 2010 Jan 14;53(1):335-44.
REF 39 Synthesis, characterization and antiglaucoma activity of a novel proton transfer compound and a mixed-ligand Zn(II) complex. Bioorg Med Chem. 2010 Jan 15;18(2):930-8.
REF 40 Carbonic anhydrase inhibitors. Inhibition of mammalian isoforms I-XIV with a series of natural product polyphenols and phenolic acids. Bioorg Med Chem. 2010 Mar 15;18(6):2159-2164.
REF 41 Carbonic anhydrase inhibitors: synthesis and inhibition of the human cytosolic isozymes I and II and transmembrane isozymes IX, XII (cancer-associa... Eur J Med Chem. 2010 Jun;45(6):2396-404.
REF 42 Carbonic anhydrase inhibitors: crystallographic and solution binding studies for the interaction of a boron-containing aromatic sulfamide with mamm... Bioorg Med Chem Lett. 2010 Jun 15;20(12):3601-5.
REF 43 Carbonic anhydrase inhibitors. Regioselective synthesis of novel 1-substituted 1,4-dihydro-4-oxo-3-pyridinesulfonamides and their inhibition of the... Eur J Med Chem. 2010 Sep;45(9):3656-61.
REF 44 A novel and one-pot synthesis of new 1-tosyl pyrrol-2-one derivatives and analysis of carbonic anhydrase inhibitory potencies. Bioorg Med Chem. 2010 Jun 15;18(12):4468-74.
REF 45 Polyamines inhibit carbonic anhydrases by anchoring to the zinc-coordinated water molecule. J Med Chem. 2010 Aug 12;53(15):5511-22.
REF 46 Mutation of Phe91 to Asn in human carbonic anhydrase I unexpectedly enhanced both catalytic activity and affinity for sulfonamide inhibitors. Bioorg Med Chem. 2010 Aug 1;18(15):5498-503.
REF 47 Carbonic anhydrase inhibitors. Antioxidant polyphenols effectively inhibit mammalian isoforms I-XV. Bioorg Med Chem Lett. 2010 Sep 1;20(17):5050-3.
REF 48 Synthesis, characterization and antiglaucoma activity of some novel pyrazole derivatives of 5-amino-1,3,4-thiadiazole-2-sulfonamide. Eur J Med Chem. 2010 Nov;45(11):4769-73.
REF 49 Paraoxon, 4-nitrophenyl phosphate and acetate are substrates of - but not of -, - and -carbonic anhydrases. Bioorg Med Chem Lett. 2010 Nov 1;20(21):6208-12.
REF 50 7,8-disubstituted- but not 6,7-disubstituted coumarins selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and X... Bioorg Med Chem Lett. 2010 Dec 15;20(24):7255-8.
REF 51 Carbonic anhydrase inhibitors. Inhibition studies of a coral secretory isoform by sulfonamides. Bioorg Med Chem. 2009 Jul 15;17(14):5054-8.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.